Search

Your search keyword '"Ciuffreda, Libero"' showing total 279 results
Start Over Author "Ciuffreda, Libero"
279 results on '"Ciuffreda, Libero"'

2. Gender-specific side effects of chemotherapy in pancreatic cancer patients

Author

De Francia, Silvia, Mancardi, Daniele, Berchialla, Paola, Armando, Tiziana, Storto, Silvana, Allegra, Sarah, Soave, Giulia, Racca, Silvia, Chiara, Francesco, Carnovale, Jennifer, Ciuffreda, Libero, and Mussa, Maria Valentina

Subjects
Medical research, Medicine, Experimental, Sex factors in disease -- Research, Drugs -- Adverse and side effects, Chemotherapy -- Complications and side effects -- Demographic aspects, Cancer -- Chemotherapy, Pancreatic cancer -- Drug therapy, Biological sciences
Abstract

Pancreatic carcinoma incidence showed a significant increase in men over the last few years and the prognosis remains poor. Patients are treated with different pharmacological plans with no evidence about gender-specific adverse effects. We aimed to investigate differences in the incidence of chemotherapy side effects in the treatment of pancreatic cancer, to provide insights toward a personalized assistance based in individual needs. The sample population is composed of 207 patients. Regression model highlighted the predictive role of female gender for alopecia, constipation, hand- foot syndrome, and epigastric pain. Also, considering single therapeutic schemes, gender differences have been reported. Moreover, evaluating the effect of age, a general reduced risk of toxicity has been reported in younger patients. To personalize chemotherapy and increase patient survival rate and life quality during the therapy, gender medicine and pharmacology studies are recommended. Key words: gender differences, adverse effects, drugs toxicity, chemotherapy, pancreatic carcinoma. La frequence du cancer du pancreas chez l'homme a decrit une courbe nettement ascendante au cours des dernieres annees et le pronostic demeure defavorable. Les patients sont traites a l'aide de differents schemas pharmacologiques sans donnees probantes quant aux effets indesirables specifiques a leur sexe. Nous avons vise a etudier les differences entre la frequence des effets indesirables de la chimiotherapie dans le traitement du cancer du pancreas en vue de fournir des elements de reflexion quant a l'aide personnalisee fondee sur des besoins individuels. La population echantillonnee est composee de 207 patients. Le modele de regression a mis en evidence le role predictif du sexe feminin quant a l'alopecie, a la constipation, au syndrome pied-main et aux douleurs epigastriques. Nous avons aussi rapporte des differences entre les sexes selon des schemas therapeutiques individuels. En outre, une evaluation selon l'age a permis de rapporter un decroissement general du risque de toxicite chez les patients jeunes. Nous recommandons de proceder a des etudes medicales et pharmacologiques selon le sexe en vue d'offrir aux patients une chimiotherapie personnalisee et de faire augmenter leur taux de survie de meme que leur qualite de vie pendant le traitement. [Traduit par la Redaction] Mots-cles : differences entre les sexes, effets indesirables, toxicite medicamenteuse, chimiotherapie, cancer du pancreas., 1. Introduction Recent studies demonstrate gender-specific incidence, progression, and severity of different tumors. Differences in parameters such as body weight, fat distribution, hormonal profile, metabolism, immune response, and genetics were [...]

Published
2022
Full Text
View/download PDF

4. Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study

Author

Rosati, Gerardo, Pinto, Carmine, Di Fabio, Francesca, Chiara, Silvana, Lolli, Ivan R., Ruggeri, Enzo M., Ciuffreda, Libero, Ferrara, Raimondo, Antonuzzo, Lorenzo, Adua, Daniela, Racca, Patrizia, Bilancia, Domenico, Benincasa, Elena, Stroppolo, Maria Elena, and Di Costanzo, Francesco

Published
2018
Full Text
View/download PDF

5. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Author

Thaler, Josef, Greil, Richard, Gaenzer, Johannes, Eisterer, Wolfgang, Tschmelitsch, Joerg, Keil, Felix, Samonigg, Hellmut, Zabernigg, August, Schmid, Franz, Steger, Günther, Steinacher, Robert, Andel, Johannes, Jagdt, Björn, Lang, Alois, Fridrik, Michael, Függer, Reinhold, Hofbauer, Friedrich, Woell, Ewald, Geissler, Dietmar, Lenauer, Alfred, Prager, Manfred, D'Haens, Geert, Demolin, Gauthier, Kerger, Joseph, Deboever, Guido, Ghillebert, Gilbert, Polus, Marc, Van Cutsem, Eric, Kalantari, Hassan Rezaie, Delaunoit, Thierry, Goeminne, Jean Charles, Peeters, Marc, Vergauwe, Philippe, Houbiers, Ghislain, Humblet, Yves, Janssens, Jos, Schrijvers, Dirk, Vanderstraeten, Erik, Van Laethem, Jean-Luc, Vermorken, Jan, Van Daele, Daniel, Ferrante, Michel, Forget, Frederic, Hendlisz, Alain, Yilmaz, Mette, Nielsen, Svend Erik, Vestermark, Lene, Larsen, Jim, Zawadi, Mohamed-Ayman, Bouche, Olivier, Mineur, Laurent, Bennouna-Louridi, Jaafar, Dourthe, Louis Marie, Ychou, Marc, Boucher, Eveline, Taieb, Julien, Pezet, Denis, Desseigne, Francoise, Ducreux, Michel, Texereau, Patrick, Miglianico, Laurent, Rougier, Philippe, Fratte, Serge, Levache, Charles-Briac, Merrouche, Yacine, Ellis, Stephen, Locher, Christophe, Ramee, Jean-Francois, Garnier, Claire, Viret, Frederic, Chauffert, Bruno, Cojean-Zelek, Isabelle, Michel, Pierre, Lecaille, Cedric, Borel, Christian, Seitz, Jean-Francois, Smith, Denis, Lombard-Bohas, Catherine, Andre, Thierry, Gornet, Jean-Marc, Fein, Francine, Coulon-Sfairi, Marie-Aude, Kaminsky, Marie-Christine, Lagasse, Jean-Paul, Luet, Dominique, Etienne, Pierre-Luc, Gasmi, Mohamed, Vanoli, Andre, Nguyen, Suzanne, Aparicio, Thomas, Perrier, Hervé, Stremsdoerfer, Noel, Laplaige, Philippe, Arsene, Dominique, Auby, Dominique, Bedenne, Laurent, Coriat, Romain, Denis, Bernard, Geoffroy, Patrick, Piot, Gilles, Becouarn, Yves, Bordes, Gilbert, Deplanque, Gael, Dupuis, Olivier, Fruge, Frederic, Guimbaud, Rosine, Lecomte, Thierry, Lledo, Gérard, Sobhani, Iradej, Asnacios, Amani, Azzedine, Ahmed, Desauw, Christophe, Galais, Marie-Pierre, Gargot, Dany, Lam, You-Heng, Abakar-Mahamat, Abakar, Berdah, Jean-Francois, Catteau, Sylviane, Clavero-Fabri, Marie-Christine, Codoul, Jean-Francois, Legoux, Jean-Louis, Goldfain, Denis, Guichard, Pierre, Verge, Denis Pere, Provencal, Jocelyne, Vedrenne, Bruno, Brezault-Bonnet, Catherine, Cleau, Denis, Desir, Jean-Paul, Fallik, David, Garcia, Bruno, Gaspard, Marie-Hélène, Genet, Dominique, Hartwig, Johannes, Krummel, Yves, Budnik, Tamara Matysiak, Palascak-Juif, Vanessa, Randrianarivelo, Harizo, Rinaldi, Yves, Aleba, Albert, Darut-Jouve, Ariane, de Gramont, Aimery, Hamon, Herve, Wendehenne, Frederic, Matzdorff, Axel, Stahl, Michael Konrad, Schepp, Wolfgang, Burk, Martin, Mueller, Lothar, Folprecht, Gunnar, Geissler, Michael, Mantovani-Loeffler, Luisa, Hoehler, Thomas, Asperger, Walter, Kroening, Hendrik, von Weikersthal, Ludwig Fischer, Fuxius, Stefan, Groschek, Matthias, Meiler, Johannes, Trarbach, Tanja, Rauh, Jacqueline, Ziegenhagen, Nicolas, Kretzschmar, Albrecht, Graeven, Ullrich, Nusch, Arnd, von Wichert, Goetz, Hofheinz, Ralf-Dieter, Kleber, Gerhard, Schmidt, Karl-Heinz, Vehling-Kaiser, Ursula, Baum, Claudia, Schuette, Jochen, Haag, Georg Martin, Holtkamp, Wilhelm, Potenberg, Jochen, Reiber, Tobias, Schliesser, Georg, Schmoll, Hans-Joachim, Schneider-Kappus, Wolfgang, Abenhardt, Wolfgang, Denzlinger, Claudio, Henning, Jan, Marxsen, Bartscht, Derigs, Hans Guenter, Lambertz, Helmut, Becker-Boost, Ingulf, Caca, Karel, Constantin, Christian, Decker, Thomas, Eschenburg, Henning, Gabius, Sigrun, Hebart, Holger, Hoffmeister, Albrecht, Horst, Heinz-August, Kremers, Stephan, Leithaeuser, Malte, Mueller, Sebastian, Wagner, Siegfried, Daum, Severin, Schlegel, Frank, Stauch, Martina, Heinemann, Volker, Maiello, Evaristo, Latini, Luciano, Zaniboni, Alberto, Amadori, Dino, Aprile, Giuseppe, Barni, Sandro, Mattioli, Rodolfo, Martoni, Andrea, Passalacqua, Rodolfo, Nicolini, Mario, Pasquini, Enzo, Rabbi, Carla, Aitini, Enrico, Ravaioli, Alberto, Barone, Carlo, Biasco, Guido, Tamberi, Stefano, Gambi, Angelo, Verusio, Claudio, Marzola, Marina, Lelli, Giorgio, Boni, Corrado, Cascinu, Stefano, Bidoli, Paolo, Vaghi, Massimo, Cruciani, Giorgio, Di Costanzo, Francesco, Sobrero, Alberto, Mini, Enrico, Petrioli, Roberto, Aglietta, Massimo, Alabiso, Oscar, Capuzzo, Federico, Falcone, Alfredo, Corsi, Domenico Cristi, Labianca, Roberto, Salvagni, Stefania, Chiara, Silvana, Ciuffreda, Libero, Ferraù, Francesco, Giuliani, Francesco, Lonardi, Sara, Gebbia, Nicola, Mantovani, Giovanni, Sanches, Evaristo, Mellidez, Juan Carlos, Santos, Pedro, Freire, Joao, Sarmento, Cristina, Costa, Luis, Pinto, Antonio Moreira, Barroso, Sergio, Santo, Jorge Espirito, Guedes, Fátima, Monteiro, Amélia, Sa, Anabela, Furtado, Irene, Salazar, Ramon, Aguilar, Enrique Aranda, Herrero, Fernando Rivera, Tabernero, Josep, Valera, Javier Sastre, Ayerbes, Manuel Valladares, Batlle, Jaime Feliu, Gil, Silvia, Esteve, Albert Abad, Garcia-Giron, Carlos, Vivanco, Guillermo Lopez, Salvia, Antonia Salud, Orduña, Vicente Alonso, Garcia, Ruth Vera, Gallego, Javier, Sureda, Bartomeu Massuti, Remon, Jordi, Safont Aguilera, Maria Jose, Nogueras, Luis Cirera, Merino, Bernado Queralt, Castro, Cristina Gravalos, de Prado, Purificacion Martinez, Pericay, Carlos Pijaume, Figueiras, Manuel Constenla, Jordan, Inmaculada Guasch, Gome Reina, Maria Jose, Garcia, Amelia Lopez-Ladron, Garcia-Ramos, Antonio Arrivi, Cervantes, Andres, Martos, Carlos Fernandez, Gaspar, Eugenio Marcuello, Montero, Ines Cabezas, Emperador, Pilar Escudero, Carbonero, Ana Leon, Castillo, Manuel Gallen, Garcia, Teresa Garcia, Lopez, Jose Garcia, Flores, Encarnacion Gonzalez, Morales, Monica Guillot, Muñoz, Marta Llanos, Martín, Ana López, Maurel, Joan, Camara, Juan Carlos, Garcia, Rosario Dueñas, Salgado, Mercedes, Busquier, Isabel Hernandez, Ruiz, Teresa Checa, Muñoa, Adelaida Lacasta, Aliguer, Miquel Nogue, de Taranco, Amalia Velasco Ortiz, Ureña, Miguel Mendez, Gaspa, Ferran Losa, Ponce, Jose Juan, Roig, Carlos Bosch, Jimenez, Pedro Valero, Brotons, Antonio Galan, Rodriguez, Santiago Albiol, Martinez, Jose Ales, Ruiz, Liliana Canosa, Ruiz, Margarita Centelles, Bridgewater, John, Glynne-Jones, Rob, Tahir, Saad, Hickish, Tamas, Cassidy, Jim, Samuel, Leslie, Emile, Jean-François, Julié, Catherine, Le Malicot, Karine, Lepage, Come, Dimet, Stéphanie, Boulagnon-Rombi, Camille, Allard, Marc-Antoine, Penault-Llorca, Frédérique, Bennouna, Jaafar, and Laurent-Puig, Pierre

Published
2017
Full Text
View/download PDF

6. Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

Author

Di Bartolomeo, Maria, Niger, Monica, Morano, Federica, Corallo, Salvatore, Antista, Maria, Tamberi, Stefano, Lonardi, Sara, Di Donato, Samantha, Berardi, Rossana, Scartozzi, Mario, Cardellino, Giovanni Gerardo, Di Costanzo, Francesco, Rimassa, Lorenza, Luporini, Alberto Gianluigi, Longarini, Raffaella, Zaniboni, Alberto, Bertolini, Alessandro, Tomasello, Gianluca, Pinotti, Graziella, Scagliotti, Giorgio, Tortora, Giampaolo, Bonetti, Andrea, Spallanzani, Andrea, Frassineti, Giovanni Luca, Tassinari, Davide, Giuliani, Francesco, Cinieri, Saverio, Maiello, Evaristo, Verusio, Claudio, Bracarda, Sergio, Catalano, Vincenzo, Basso, Michele, Ciuffreda, Libero, De Vita, Ferdinando, Parra, Hector Soto, Fornaro, Lorenzo, Caporale, Marta, de Braud, Filippo, and Pietrantonio, Filippo

Published
2019
Full Text
View/download PDF

7. Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis

Author

Palmerini, Emanuela, primary, Sanfilippo, Roberta, additional, Grignani, Giovanni, additional, Buonadonna, Angela, additional, Romanini, Antonella, additional, Badalamenti, Giuseppe, additional, Ferraresi, Virginia, additional, Vincenzi, Bruno, additional, Comandone, Alessandro, additional, Pizzolorusso, Antonio, additional, Brunello, Antonella, additional, Gelsomino, Fabio, additional, De Pas, Tommaso, additional, Ibrahim, Toni, additional, Gurrieri, Lorena, additional, Grosso, Federica, additional, Zanelli, Francesca, additional, Pantaleo, Maria Abbondanza, additional, Milesi, Laura, additional, Ciuffreda, Libero, additional, Ferrari, Vittorio, additional, Marchesi, Emanuela, additional, Quattrini, Irene, additional, Righi, Alberto, additional, Setola, Elisabetta, additional, Carretta, Elisa, additional, Casali, Paolo G., additional, Picci, Piero, additional, and Ferrari, Stefano, additional

Published
2022
Full Text
View/download PDF

8. Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)

Author

Bennouna, Jaafar, Havel, Libor, Krzakowski, Maciej, Kollmeier, Jens, Gervais, Radj, Dansin, Eric, Serke, Monika, Favaretto, Adolfo, Szczesna, Aleksandra, Cobo, Manuel, Ciuffreda, Libero, Jassem, Jacek, Nicolini, Mario, Ramlau, Rodryg, Amoroso, Domenico, Melotti, Barbara, Almodovar, Teresa, Riggi, Marcello, Caux, Noël-Raphaël, Vaissière, Nathalie, and Tan, Eng-Huat

Published
2014
Full Text
View/download PDF

10. GENDER-SPECIFIC SIDE EFFECTS OF CHEMOTHERAPY IN PANCREATIC CANCER PATIENTS

Author

De Francia, Silvia, primary, Mancardi, Daniele, additional, Berchialla, Paola, additional, Armando, Tiziana, additional, Storto, Silvana, additional, Allegra, Sarah, additional, Soave, Giulia, additional, Racca, Silvia, additional, Chiara, Francesco, additional, Carnovale, Jennifer, additional, Ciuffreda, Libero, additional, and Mussa, Maria Valentina, additional

Published
2021
Full Text
View/download PDF

12. Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

Author

Leone, Francesco, Marino, Donatella, Cereda, Stefano, Filippi, Roberto, Belli, Carmen, Spadi, Rosella, Nasti, Guglielmo, Montano, Massimo, Amatu, Alessio, Aprile, Giuseppe, Cagnazzo, Celeste, Fasola, Gianpiero, Siena, Salvatore, Ciuffreda, Libero, Reni, Michele, and Aglietta, Massimo

Published
2016
Full Text
View/download PDF

13. Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncology

Author

Aurilio, Gaetano, Gori, Stefania, Nolè, Franco, Pruneri, Giancarlo, Coati, Francesca, Torri, Valter, Lunardi, Gianluigi, Atzori, Francesco, La Verde, Nicla, Banna, Giuseppe Luigi, Rossi, Antonio, Del Mastro, Lucia, Di Fabio, Francesca, Marcon, Ilaria, Gebbia, Vittorio, Loupakis, Fotios, Orlando, Laura, Ciuffreda, Libero, Amadio, Placido, Luppi, Gabriele, Redana, Stefania, Filippelli, Gianfranco, Gentile, Annalisa, and Collovà, Elena

Published
2016
Full Text
View/download PDF

14. sj-docx-4-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-4-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

15. sj-docx-7-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-7-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

16. sj-docx-2-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-2-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

17. sj-docx-8-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-8-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

18. sj-pptx-3-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-pptx-3-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

19. sj-pptx-6-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-pptx-6-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

20. sj-pptx-5-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-pptx-5-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

21. sj-docx-9-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-9-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

22. sj-docx-1-tam-10.1177_17588359211022905 – Supplemental material for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, and de Castro, Gilberto

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-1-tam-10.1177_17588359211022905 for Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03) by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet and Gilberto de Castro in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

24. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

Author

Rosati, Gerardo, primary, Lonardi, Sara, additional, Galli, Fabio, additional, Di Bartolomeo, Maria, additional, Ronzoni, Monica, additional, Zampino, Maria G., additional, Banzi, Maria, additional, Zaniboni, Alberto, additional, Pasini, Felice, additional, Bozzarelli, Silvia, additional, Garattini, Silvio K., additional, Ferrari, Daris, additional, Montesarchio, Vincenzo, additional, Mambrini, Andrea, additional, Ciuffreda, Libero, additional, Galli, Francesca, additional, Pusceddu, Valeria, additional, Carlomagno, Chiara, additional, Bidoli, Paolo, additional, Amoroso, Domenico, additional, Bochicchio, Anna M., additional, Frassineti, Luca, additional, Corsi, Domenico, additional, Bilancia, Domenico, additional, Pastorino, Alessandro, additional, De Stefano, Alfonso, additional, Labianca, Roberto, additional, Bilancia, D., additional, Rosati, G., additional, Montesarchio, V., additional, Iaffaioli, R.V., additional, Nasti, G., additional, Daniele, B., additional, Zagonel, V., additional, Lonardi, S., additional, Pella, N., additional, Aprile, G., additional, Pasini, F., additional, Marchetti, Roma P., additional, Romiti, A., additional, Ciuffreda, L., additional, Ferrari, D., additional, Foa, P., additional, Zaniboni, A., additional, Labianca, R., additional, Mosconi, S., additional, Sobrero, A., additional, Bidoli, P., additional, Cazzaniga, M., additional, Beretta, G.D., additional, Corsi, D.C., additional, Cortesi, E., additional, Barni, S., additional, Petrelli, F., additional, Allione, P., additional, D'Arco, A.M., additional, Valmadre, G., additional, Piazza, E., additional, Veltri, E., additional, Ramus, G. Vietti, additional, Giustini, L., additional, Tumulo, S., additional, Cascinu, S., additional, Granetto, C., additional, Testore, F., additional, Giordano, M., additional, Moroni, M., additional, Di Seri, M., additional, Nuzzo, A., additional, Angelelli, L., additional, Gori, S., additional, Farina, G., additional, Aglietta, M., additional, Franchi, R., additional, Comandé, M., additional, Giordani, P., additional, Tonini, G., additional, Bucci, E., additional, Ballestrero, A., additional, Benasso, M., additional, Graiff, C., additional, Bravi, S., additional, Caffo, O., additional, Silva, R.R., additional, Frontini, L., additional, Rota, S., additional, Cozzi, L., additional, Cantore, M., additional, Maiello, E., additional, Cinieri, S., additional, Silvestris, N., additional, Romito, S., additional, Gebbia, V., additional, Banzi, M., additional, Santoro, A., additional, Artioli, F., additional, Mattioli, R., additional, Contu, A., additional, Di Costanzo, F., additional, Leonardi, F., additional, Cavanna, L., additional, Passalacqua, R., additional, Amoroso, D., additional, Sozzi, P., additional, D'Amico, M., additional, Amadori, D., additional, Frassineti, L., additional, Turci, D., additional, Ravaioli, A., additional, Pasquini, E., additional, Gambi, A., additional, Faedi, M., additional, Cruciani, G., additional, Bajetta, E., additional, Di Bartolomeo, M., additional, Gianni, L., additional, Ronzoni, M., additional, Ionta, M.T., additional, Massidda, B., additional, Scartozzi, M., additional, Zampino, M.G., additional, Bochicchio, A.M., additional, Ciarlo, A., additional, Di Leo, A., additional, Frustaci, S., additional, Rangoni, G., additional, Arizzoia, A., additional, Pavesi, L., additional, Verusio, C., additional, Pinotti, G., additional, Iop, A., additional, De Placido, S., additional, Carlomagno, C., additional, Adamo, V., additional, Ficorella, C., additional, Natale, D., additional, Greco, E., additional, Rulli, E., additional, Galli, F., additional, Poli, D., additional, Porcu, L., additional, and Torri, V., additional

Published
2021
Full Text
View/download PDF

29. Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group

Author

Palmerini, Emanuela, primary, Sanfilippo, Roberta, additional, Grignani, Giovanni, additional, Buonadonna, Angela, additional, Romanini, Antonella, additional, Badalamenti, Giuseppe, additional, Ferraresi, Virginia, additional, Vincenzi, Bruno, additional, Comandone, Alessandro, additional, Pizzolorusso, Antonio, additional, Brunello, Antonella, additional, Gelsomino, Fabio, additional, Pas, Tommaso De, additional, Ibrahim, Toni, additional, Grosso, Federica, additional, Zanelli, Francesca, additional, Pantaleo, Maria Abbondanza, additional, Milesi, Laura, additional, Ciuffreda, Libero, additional, Ferrari, Vittorio, additional, Marchesi, Emanuela, additional, Quattrini, Irene, additional, Righi, Alberto, additional, Setola, Elisabetta, additional, Carretta, Elisa, additional, Picci, Piero, additional, and Ferrari, Stefano, additional

Published
2021
Full Text
View/download PDF

30. 68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients

Author

Liberini, Virginia, primary, Rampado, Osvaldo, additional, Gallio, Elena, additional, De Santi, Bruno, additional, Ceci, Francesco, additional, Dionisi, Beatrice, additional, Thuillier, Philippe, additional, Ciuffreda, Libero, additional, Piovesan, Alessandro, additional, Fioroni, Federica, additional, Versari, Annibale, additional, Molinari, Filippo, additional, and Deandreis, Désirée, additional

Published
2021
Full Text
View/download PDF

31. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Author

Grossi, Francesco, primary, Jaśkiewicz, Piotr, additional, Ferreira, Marion, additional, Czyżewicz, Grzegorz, additional, Kowalski, Dariusz, additional, Ciuffreda, Libero, additional, Garcia-Gomez, Ramon, additional, Caruso, Salvatore, additional, Bosch-Barrera, Joaquim, additional, Gautier, Stéphanie, additional, Ta Thanh Minh, Christine, additional, Henriet, Sébastien, additional, and de Castro, Gilberto, additional

Published
2021
Full Text
View/download PDF

35. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer

Author

Petrelli, Fausto, primary, Labianca, Roberto, additional, Zaniboni, Alberto, additional, Lonardi, Sara, additional, Galli, Fabio, additional, Rulli, Eliana, additional, Rosati, Gerardo, additional, Corallo, Salvatore, additional, Ronzoni, Monica, additional, Cardellino, Giovanni Gerardo, additional, Mattioli, Rodolfo, additional, Mambrini, Andrea, additional, Ciuffreda, Libero, additional, Banzi, Maria, additional, Pusceddu, Valeria, additional, Maiello, Evaristo, additional, Zampino, Maria, additional, Zagonel, Vittorina, additional, Marchetti, Paolo, additional, Corsi, Domenico, additional, Rimassa, Lorenza, additional, Cinieri, Saverio, additional, and Sobrero, Alberto, additional

Published
2020
Full Text
View/download PDF

37. SAFETY AND EFFICACY OF SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (mRCC): PRELIMINARY ASSESSMENT OF AN ITALIAN EXPANDED-ACCESS PROGRAM (EAP) WITH SUBPOPULATION ANALYSIS: 1217

Author

Sternberg, Cora N, Porta, Camillo, Bracarda, Sergio, Carteni, Giacomo, Re, Giovanni Lo, Ruggeri, Enzo M, Conte, Pierfranco, Monfardini, Silvio, Gasparini, Giampietro, Ciuffreda, Libero, Marini, Giovanni, Bonetti, Andrea, Heouaine, Abdhelhamid, Bernardini, Ilaria, Ravaioli, Alberto, and Labianca, Roberto

Published
2008

41. FOLLOW UP OF 15 CASES OF MERKEL'S CELL CARCINOMA

Author

Ciuffreda, Libero, Caliendo, Virginia, Birocco, Nadia, Dongiovanni, Vincenzo, Ronco, Anna Maria, Berruti, Alfredo, Fanchini, Laura, Volante, Marco, Papotti, Mauro, Macripò, Giuseppe, Dogliotti, Luigi, and Bertetto, Oscar

Published
2001

44. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial

Author

Capelletto, Enrica, primary, Migliorino, Maria Rita, additional, Morabito, Alessandro, additional, Chiari, Rita, additional, Grossi, Francesco, additional, Tiseo, Marcello, additional, Costanzo, Francesco Di, additional, Delmonte, Angelo, additional, Romano, Gianpiero, additional, Galetta, Domenico, additional, Scotti, Vieri, additional, Gregorc, Vanesa, additional, Pisconti, Salvatore, additional, Ceresoli, Giovanni Luca, additional, Del Conte, Alessandro, additional, Ciuffreda, Libero, additional, Colantonio, Ida, additional, Bria, Emilio, additional, Ricciardi, Serena, additional, Manzo, Anna, additional, Metro, Giulio, additional, Morelli, Anna Maria, additional, Critelli, Rossana, additional, Pacchiana, Maria Vittoria, additional, Stura, Ilaria, additional, Migliaretti, Giuseppe, additional, and Novello, Silvia, additional

Published
2019
Full Text
View/download PDF

45. Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study

Author

Lonardi, Sara, primary, Nasti, Guglielmo, additional, Fagnani, Daniele, additional, Gemma, Donatello, additional, Ciuffreda, Libero, additional, Granetto, Cristina, additional, Lucchesi, Sara, additional, Ballestrero, Alberto, additional, Biglietto, Maria, additional, Proserpio, Ilaria, additional, Bergamo, Francesca, additional, Proietti, Emanuela, additional, and Tonini, Giuseppe, additional

Published
2019
Full Text
View/download PDF

46. Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

Author

Crinò, Lucio, primary, Bronte, Giuseppe, additional, Bidoli, Paolo, additional, Cravero, Paola, additional, Minenza, Elisa, additional, Cortesi, Enrico, additional, Garassino, Marina C., additional, Proto, Claudia, additional, Cappuzzo, Federico, additional, Grossi, Francesco, additional, Tonini, Giuseppe, additional, Sarobba, Maria Giuseppina, additional, Pinotti, Graziella, additional, Numico, Gianmauro, additional, Samaritani, Riccardo, additional, Ciuffreda, Libero, additional, Frassoldati, Antonio, additional, Bregni, Marco, additional, Santo, Antonio, additional, Piantedosi, Francovito, additional, Illiano, Alfonso, additional, De Marinis, Filippo, additional, Tamberi, Stefano, additional, Giannarelli, Diana, additional, and Delmonte, Angelo, additional

Published
2019
Full Text
View/download PDF

47. Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study

Author

Berardi, Rossana, primary, Mastroianni, Candida, additional, Lo Russo, Giuseppe, additional, Buosi, Roberta, additional, Santini, Daniele, additional, Montanino, Agnese, additional, Carnaghi, Carlo, additional, Tiseo, Marcello, additional, Chiari, Rita, additional, Camerini, Andrea, additional, Barni, Sandro, additional, De Marino, Valeria, additional, Ferrari, Daris, additional, Cristofano, Antonella, additional, Doni, Laura, additional, Freddari, Federica, additional, Fumagalli, Daniele, additional, Portalone, Luigi, additional, Sarmiento, Roberta, additional, Schinzari, Giovanni, additional, Sperandi, Francesca, additional, Tucci, Marcello, additional, Inno, Alessandro, additional, Ciuffreda, Libero, additional, Mariotti, Marita, additional, Mariani, Cinzia, additional, Caramanti, Miriam, additional, Torniai, Mariangela, additional, Gallucci, Rosaria, additional, Bennati, Chiara, additional, Bordi, Paola, additional, Buffoni, Lucio, additional, Galeassi, Achille, additional, Ghidini, Michele, additional, Grossi, Emidio, additional, Morabito, Alessandro, additional, Vincenzi, Bruno, additional, and Arvat, Emanuela, additional

Published
2019
Full Text
View/download PDF

48. Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

Author

Ciuffreda Libero, Alabiso Oscar, Ferretti Benedetta, Perroni Davide, Bombaci Sebastiano, Birocco Nadia, Castiglione Federico, Volante Marco, Milanesi Enrica, Ferrero Anna, Berruti Alfredo, Brizzi Maria P, Bertetto Oscar, Papotti Mauro, and Dogliotti Luigi

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Well-differentiated neuroendocrine carcinomas are highly vascularized and may be sensitive to drugs administered on a metronomic schedule that has shown antiangiogenic properties. A phase II study was designed to test the activity of protracted 5-fluorouracil (5FU) infusion plus long-acting release (LAR) octreotide in patients with neuroendocrine carcinoma. Methods Twenty-nine patients with metastatic or locally advanced well-differentiated neuroendocrine carcinoma were treated with protracted 5FU intravenous infusion (200 mg/m2 daily) plus LAR octreotide (20 mg monthly). Patients were followed for toxicity, objective response, symptomatic and biochemical response, time to progression and survival. Results Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) criteria showed partial response in 7 (24.1%), stable disease in 20 (69.0%), and disease progression in 2 patients. Response did not significantly differ when patients were stratified by primary tumor site and proliferative activity. A biochemical (chromogranin A) response was observed in 12/25 assessable patients (48.0%); symptom relief was obtained in 9/15 symptomatic patients (60.0%). There was non significant decrease in circulating vascular epithelial growth factor (VEGF) over time. Median time to progression was 22.6 months (range, 2.7-68.5); median overall survival was not reached yet. Toxicity was mild and manageable. Conclusion Continuous/metronomic 5FU infusion plus LAR octreotide is well tolerated and shows activity in patients with well-differentiated neuroendocrine carcinoma. The potential synergism between metronomic chemotherapy and antiangiogenic drugs provides a rationale for exploring this association in the future. Trial registration NCT00953394

Published
2009
Full Text
View/download PDF

49. Correlation between NK function and response to trastuzumab in metastatic breast cancer patients

Author

Spadi Rosella, Polimeni Maria, Mistrangelo Marinella, Brusa Davide, Evangelista Andrea, Signorino Elena, Beano Alessandra, Donadio Michela, Ciuffreda Libero, and Matera Lina

Subjects
Medicine
Abstract

Abstract Background Trastuzumab is a monoclonal antibody selectively directed against Her2 and approved for the treatment of Her2 overexpressing breast cancer patients. Its proposed mechanisms of action include mediation of antibody-dependent cellular cytotoxicity (ADCC) by triggering FcγRIII on natural killer (NK) cells. This study addresses the correlation between overall NK function and trastuzumab's clinical activity. Subjects and methods Clinical and immunological responses were assessed in 26 patients receiving trastuzumab monotherapy as maintenance management after chemotherapy (8 mg/kg load and then standard doses of 6 mg/kg every 3 weeks). Cytotoxic activity against the MHC class I-negative standard NK target K562 cell line and HER2-specific ADCC against a trastuzumab-coated Her2-positive SKBR3 cell line were assessed in peripheral blood mononuclear cells (PBMC) harvested after the first standard dose. After six months, seventeen patients were scored as responders and nine as non-responders according to the RECIST criteria, while Progression-Free Survival (PFS) was calculated during a 12 months follow-up. Results The responders had significantly higher levels of both NK and ADCC activities (p < 0.05) that were not different from those of eleven normal controls. The NK activity of the non-responders was significantly (p < 0.05) lower than that of the normal controls. At twelve months, there was a marked correlation between PFS and NK activity only. PFS was significantly longer in patients with high levels of NK activity, whereas its pattern was unrelated to high or low ADCC activity. Conclusion One of the mechanisms of action of trastuzumab is NK cell-mediated ADCC lysis of the Her2-positve target cell. We show here that its potency is correlated with the short-term response to treatment, whereas longer protection against tumor expansion seems to be mediated by pure NK activity.

Published
2008
Full Text
View/download PDF

50. Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Author

Pastorino, Alessandro, primary, Di Bartolomeo, Maria, additional, Maiello, Evaristo, additional, Iaffaioli, Vincenzo, additional, Ciuffreda, Libero, additional, Fasola, Gianpiero, additional, Di Costanzo, Francesco, additional, Frassineti, Giovanni Luca, additional, Marchetti, Paolo, additional, Antoniotti, Carlotta, additional, Leone, Francesco, additional, Zaniboni, Alberto, additional, Aprile, Giuseppe, additional, Zilocchi, Chiara, additional, Sobrero, Alberto, additional, and Bordonaro, Roberto, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results